Abstracts

599 – Polypharmacy Is Associated With Neuronal Injury in PWH

Background Polypharmacy, or the use of five or more non-ART prescription medications, promote neurologic disorders and geriatric syndromes. However, it is unknown if this is mediated by neuronal damage incurred by multiple medications, by inflammation, or by high comorbidity burden necessitating the use of multiple medications. To better understand how polypharmacy influences neurologic disorder in…

605 – Longitudinal Changes in Neuronal Markers and Associations With ART Initiation and Cognitive Function

Background Improvement in cognitive function is described in persons with HIV commencing ART for the first time. We assessed the impact of initiating either dual or triple ART on longitudinal changes in biomarkers of neuronal inflammation and injury, and their associations with cognitive function. Methods Biomarker concentrations were assessed at baseline (W0) and after 96…

492 – Post-Treatment HIV Controllers Exhibit Reduced Plasma Markers of Inflammation and Metabolic Stress

Background A rare subset of people with HIV (PWH) on antiretroviral therapy (ART), known as post-treatment controllers (PTCs), can maintain viral suppression for extended periods after treatment interruption (TI). The mechanisms underlying this clinically valuable phenotype remain unclear and are likely multifactorial, necessitating further comprehensive analysis. Methods Pre-TI levels of 247 inflammation and immunomodulatory markers…

629 – Adenosine, Guardian of the Brain: Possible Role in Protecting From HIV Neuropathogenesis

Background Due to its regulatory properties, adenosine has been recognized as a guardian molecule with many protective functions in and out of the brain. For example, HIV silencing in T-cells has been associated with upregulating the adenosine-producing ecto-5’-nucleotidase Nt5e (known as CD73). We hypothesized that under HIV-induced inflammatory conditions in the brain extracellular ATP/adenosine would increase and…

502 – Targeting TCF-1 to Potentiate the Functional Capacity of HIV/SIV-Specific CD8+ T Cells

Background The transcription factor T cell factor 1 (TCF-1) plays a critical role in maintaining functional memory CD8+ T cells and regulation of their proliferation capacity. TCF-1 expression in HIV-specific CD8+ T cells has been associated with viral control and may be important for promoting the functional activity of HIV-specific CD8+ T cells. Glycogen synthase kinase-3 (GSK-3) inhibitors…

594 – Analyzing Neuroanatomical Heterogeneity in HIV-Associated Cognitive Impairment

Background Central Nervous System (CNS) complications among people living with HIV (PWH) are common, but treatments remain elusive, likely due to underlying heterogeneity. Here, we aim to characterize neurobiological heterogeneity in PWH by leveraging machine learning and neuroimaging data in a large, well-characterized cohort. Methods We analyzed structural Magnetic Resonance Imaging (sMRI) data from 610…

587 – HIV Transcriptional Regulation in the CNS of ART-Suppressed People With HIV

Background We and others have previously demonstrated that intact, transcriptionally competent HIV genomes persist within the brain of virally suppressed people with HIV (PWH). Long terminal repeats (LTRs) isolated from the brain of non-virally suppressed PWH are genetically distinct from those isolated in matched peripheral tissue and have a reduced responsiveness to select latency reversing…

517 – Biomarkers of HIV Latency in Tissues From People With HIV

Background Identifying biomarkers of latently infected cells is essential for eliminating the HIV reservoir. Since HIV proviruses exhibit activity even during latency, single-cell (sc) RNA-seq can detect gene expression patterns in these cells. Our prior in vitro study (PMID 38156317) revealed that transcriptional profiles of latent HIV+ cells vary depending on the environment, though certain…

575 – HIV Reactivation Potential Evaluated by RNA-Seq and DNA Methylation Following LRA Stimulation

Background Latency-reversing agents (LRAs) have shown promise in reactivating HIV reservoir within “shock and kill”approaches. However, molecular mechanisms underlying HIV reactivation within CD4+ T cells as well as predictors of LRA efficacy remain partially unknown. Here, we investigated the transcriptomic and whole genome DNA methylation profile of CD4+ T cells cultured in vitro with or…